問卷

TPIDB > Principal Investigator

Principal Investigator


Taipei Veterans General Hospital (在職)

Division of Infectious Disease

更新時間:2023-09-19

林邑璁LIN, YI-TSUNG
  • Principal Investigator
  • Clinical Trial Experience (year) 12 years 9 個月

篩選

List

17Cases

2022-10-01 - 2028-06-22

Phase III

Active
xxxxxx
  • Condition/Disease

    xxxxxx

  • Test Drug

    xxxxxx

Participate Sites
8Sites

Recruiting8Sites

2025-03-31 - 2028-06-30

Others

Not yet recruiting
A Retrospective, Observational, Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Infusions of Polymyxin B and Colistin Methanesulfonate in Patients with Carbapenem-Resistant Gram-Negative Bacterial Infection
  • Condition/Disease

    Carbapenem-Resistant Gram-Negative Bacterial Infection

  • Test Drug

    injection

Participate Sites
13Sites

Recruiting13Sites

2022-10-01 - 2026-01-16

Phase III

An Interventional Efficacy and Safety Phase 3 Double-blind 2-arm Study to Investigate IV Followed by Oral Fosmanogepix Compared With IV Caspofungin Followed by Oral Fluconazole in Adult Participants With Candidemia and/or Invasive Candidiasis
  • Condition/Disease

    Adult patients with candidemia and/or invasive candidiasis

  • Test Drug

    Fosmanogepix CANCIDAS Fosmanogepix Caspofungin Fluconazole

Participate Sites
8Sites

Not yet recruiting8Sites

2014-02-04 - 2015-02-11

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

2022-01-03 - 2022-10-28

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Recruiting4Sites

2023-01-01 - 2023-01-24

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Terminated7Sites

2017-07-01 - 2018-09-30

Phase II

A Phase 2, Double-blind, Randomized Controlled Study to Evaluate Immunogenicity and Safety of Intranasal Trivalent Influenza Virus Vaccine in Healthy Adult Volunteers
  • Condition/Disease

    Influenza Virus Vaccine

  • Test Drug

    AD07030

Participate Sites
5Sites

Terminated5Sites

1 2